Sec Form 13G Filing - Kumar Neil filing for - 2026-04-16

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
X0202 SCHEDULE 13G/A 0000950170-25-020045 0001742485 XXXXXXXX LIVE 6 Common Stock, par value $0.001 per share 03/31/2026 0001743881 BridgeBio Pharma, Inc. 10806X102 3160 Porter Street, Suite 250 Palo Alto CA 94304 Rule 13d-1(d) NEIL KUMAR b X1 4208849.00 5074133.00 4208849.00 5074133.00 9282982.00 N 4.6 IN (1) Consists of (i) 234,451 shares of Common Stock held directly by Dr. Kumar, (ii) 3,903,183 shares of Common Stock issuable to Dr. Kumar upon the exercise of stock options exercisable within 60 days of March 31, 2026, (iii) 71,215 shares of Common Stock issuable to Dr. Kumar upon the vesting and settlement of restricted stock units within 60 days of March 31, 2026, (iv) 4,438,447 shares of Common Stock held by the Kumar Haldea Revocable Trust, of which Dr. Kumar is a co-trustee and (v) 635,686 shares of Common Stock held by the Kumar Haldea Family Irrevocable Trust, of which Dr. Kumar is a co-trustee. (2) Percentage ownership is based on (i) 195,707,702 shares of Common Stock outstanding as of March 31, 2026, (ii) 3,903,183 shares of Common Stock underlying stock options held by Dr. Kumar that are exercisable within 60 days of March 31, 2026 and are deemed outstanding pursuant to SEC Rule 13-3(d)(1)(i) and (iii) 71,215 shares of Common Stock underlying restricted stock units held by Dr. Kumar that are subject to vesting and settlement within 60 days of March 31, 2026 and are deemed outstanding pursuant to SEC Rule 13-3(d)(1)(i). BridgeBio Pharma, Inc. 3160 Porter Street, Suite 250, Palo Alto, California, 94304 NEIL KUMAR 3160 Porter Street, Suite 250, Palo Alto, California 94304 U.S. Y 9,282,982 shares of Common Stock, which represents (i) 234,451 shares of Common Stock held of record by Dr. Kumar, (ii) 3,903,183 shares of Common Stock issuable to Dr. Kumar upon the exercise of stock options exercisable within 60 days of March 31, 2026, (iii) 71,215 shares of Common Stock issuable to Dr. Kumar upon the vesting and settlement of restricted stock units within 60 days of March 31, 2026, (iv) 4,438,447 shares of Common Stock held of record by Kumar Haldea Revocable Trust and (v) 635,686 shares of Common Stock held of record by the Kumar Haldea Family Irrevocable Trust. 4.6% 4,208,849 5,074,133 4,208,849 5,074,133 N Y N Not Applicable N Not Applicable N Not Applicable N Not Applicable Y NEIL KUMAR /s/ Neil Kumar Neil Kumar 04/16/2026 primary_doc.xml